Selecta Biosciences Inc (SELB)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -61.723 | -68.614 | -89.758 | -76.848 | -51.981 | -15.792 | 21.72 | -93.308 |
Return on Equity (%) | 132.527 | -122.357 | -281.645 | -3716.012 | 1433.573 | -1137.852 | 60.815 | 126.869 |
Return on Invested Capital (%) | 157.505 | -94.479 | -194.589 | -7941.711 | -942.618 | -76.748 | 20.061 | 365.76 |
Operating Margin (%) | -432.476 | -30973.43 | -7069.989 | -806.215 | -405.615 | -8.083 | 34.124 | -907.08 |
Net Profit Margin (%) | -504.466 | -31556.039 | -7235.437 | -828.965 | -414.991 | -30.193 | 31.937 | -844.908 |
Book Value Per Share | 2.98 | 2.319 | -0.241 | 0.097 | -0.167 | 0.182 | 0.613 | -2.18 |
Earnings Per Share | -2.211 | -2.924 | -2.907 | -0.641 | -0.637 | -0.208 | 0.231 | -1.416 |
Cash Per Share | 3.181 | 3.161 | 1.664 | 1.041 | 1.283 | 0.923 | 0.695 | 0.496 |
Working Capital Per Share | 3.965 | 3.925 | 0.308 | 0.715 | 0.646 | 0.584 | 0.804 | 0.145 |
Operating Profit Per Share | 0.438 | 0.009 | 0.04 | 0.077 | 0.154 | 0.688 | 0.724 | 0.168 |
EBIT Per Share | -1.964 | -2.924 | -2.907 | -0.641 | -0.637 | -0.079 | 0.227 | -1.538 |
EBITDA Per Share | -1.964 | -2.924 | -2.907 | -0.641 | -0.637 | -0.079 | 0.227 | -1.538 |
Free Cash Flow Per Share | -2.223 | -2.927 | -2.913 | -0.649 | -0.637 | -0.204 | 0.234 | -1.42 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 18,44M | 22,34M | 22,47M | 86,33M | 108,07M | 123,62M | 153,04M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 153,04M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -351.213 | N/A | N/A | N/A | -973.014 | N/A | N/A |
Net Profit Margin (%) | N/A | -364.82 | N/A | N/A | N/A | -973.014 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 136,77M |
Ratio cours/bénéfice | -11,95 |
Ratio prix/ventes | 101,01 |
Ratio prix/liquidités | 34,15 |
Ratio prix/valeur comptable | -18,81 |
Rendement de dividende | - |
Actions en circulation | 155,2M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales